Neuro-oncology

TMOD-27. A NEURAL CREST CELL SUBPOPULATION UNDERLIES INTRATUMOR HETEROGENEITY IN MENINGIOMA.

Neuro-oncology

Stephen Magill, Harish Vasudevan, Kyounghee Seo, S John Liu, Stephanie Hilz, Javier Villanueva-Meyer, Abrar Choudhury, Benjamin Demaree, Daniel Lim, Steve Braunstein, Nancy Ann Oberheim-Bush, Erik Ullian, Manish Aghi, Philip Theodosopoulos, Patricia Sneed, Adam Abate, Mitchel Berger, Mike McDermott, Joseph Costello, David Raleigh

GENE-39. CRISPRi-BASED RADIATION MODIFIER SCREEN IDENTIFIES LONG NON-CODING RNA THERAPEUTIC TARGETS IN GLIOMA.

Neuro-oncology

S John Liu, Martina Malatesta, Kyounghee Seo, Brian Lien, Sung Hong, Mark Koontz, David Raleigh, Erik Ullian, Daniel Lim

GENE-37. VESTIBULAR SCHWANNOMA IS COMPRISED OF NEURAL CREST AND IMMUNE SUBGROUPS.

Neuro-oncology

S John Liu, Harish Vasudevan, Melike Pekmezci, Abrar Choudhury, Brian Lien, Jonathan Breshears, Danielle Swaney, Stephen Magill, Ursula Lang, William Chen, Chetna Gopinath, Maria Castro, Javier Villanueva-Meyer, Steve Braunstein, Patricia Sneed, Daniel Lim, Arie Perry, Nevan Krogran, Mike McDermott, Mitchel Berger, Philip Theodosopoulos, David Raleigh

Betacellulin drives therapy-resistance in glioblastoma.

Neuro-oncology

Fan Q, An Z, Wong RA, Luo X, Lu E, Baldwin A, Mayekar MK, Haderk F, Shokat KM, Bivona TG, Weiss WA

Germline genetic landscape of pediatric central nervous system (CNS) tumors.

Neuro-oncology

Muskens IS, Zhang C, de Smith AJ, Biegel JA, Walsh KM, Wiemels JL

Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations.

Neuro-oncology

Miklja Z, Pasternak A, Stallard S, Nicolaides T, Kline-Nunnally C, Cole B, Beroukhim R, Bandopadhayay P, Chi S, Ramkissoon SH, Mullan B, Bruzek AK, Gauthier A, Garcia T, Atchison C, Marini B, Fouladi M, Parsons DW, Leary S, Mueller S, Ligon KL, Koschmann C

Advances in multidisciplinary therapy for meningiomas.

Neuro-oncology

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR

Using germline variants to estimate glioma and subtype risks.

Neuro-oncology

Eckel-Passow JE, Decker PA, Kosel ML, Kollmeyer TM, Molinaro AM, Rice T, Caron A, Drucker KL, Praska C, Pekmezci M, Hansen HM, McCoy LS, Bracci PM, Erickson BJ, Lucchinetti C, Wiemels J, Wiencke JK, Bondy ML, Melin B, Burns TC, Giannini C, Lachance DH, Wrensch M, Jenkins RB

Pages